Abstract
Summary
The global Structural Heart Disease Interventional Device market size is projected to grow from US$ 83540 million in 2023 to US$ 282050 million in 2030; it is expected to grow at a CAGR of 19.0% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Structural Heart Disease Interventional Device Industry Forecast” looks at past sales and reviews total world Structural Heart Disease Interventional Device sales in 2023, providing a comprehensive analysis by region and market sector of projected Structural Heart Disease Interventional Device sales for 2024 through 2030. With Structural Heart Disease Interventional Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Structural Heart Disease Interventional Device industry.
This Insight Report provides a comprehensive analysis of the global Structural Heart Disease Interventional Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Structural Heart Disease Interventional Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Structural Heart Disease Interventional Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Structural Heart Disease Interventional Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Structural Heart Disease Interventional Device.
United States market for Structural Heart Disease Interventional Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Structural Heart Disease Interventional Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Structural Heart Disease Interventional Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Structural Heart Disease Interventional Device players cover Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic and Terumo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Structural Heart Disease Interventional Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Percutaneous Interventional Devices
Thoracotomy Instruments
Segmentation by application
Congenital Heart Disease
Valvular Disease
Cardiomyopathy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Boston Scientific
Edwards Lifesciences
Medtronic
Terumo
B. Braun
Lepu Medical
Koninklijke Philips NV
Biosensors International
Meril Life Sciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Structural Heart Disease Interventional Device market?
What factors are driving Structural Heart Disease Interventional Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Structural Heart Disease Interventional Device market opportunities vary by end market size?
How does Structural Heart Disease Interventional Device break out type, application?
LP Information, Inc. (LPI) ' newest research report, the “Structural Heart Disease Interventional Device Industry Forecast” looks at past sales and reviews total world Structural Heart Disease Interventional Device sales in 2023, providing a comprehensive analysis by region and market sector of projected Structural Heart Disease Interventional Device sales for 2024 through 2030. With Structural Heart Disease Interventional Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Structural Heart Disease Interventional Device industry.
This Insight Report provides a comprehensive analysis of the global Structural Heart Disease Interventional Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Structural Heart Disease Interventional Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Structural Heart Disease Interventional Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Structural Heart Disease Interventional Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Structural Heart Disease Interventional Device.
United States market for Structural Heart Disease Interventional Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Structural Heart Disease Interventional Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Structural Heart Disease Interventional Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Structural Heart Disease Interventional Device players cover Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic and Terumo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Structural Heart Disease Interventional Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Percutaneous Interventional Devices
Thoracotomy Instruments
Segmentation by application
Congenital Heart Disease
Valvular Disease
Cardiomyopathy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Boston Scientific
Edwards Lifesciences
Medtronic
Terumo
B. Braun
Lepu Medical
Koninklijke Philips NV
Biosensors International
Meril Life Sciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Structural Heart Disease Interventional Device market?
What factors are driving Structural Heart Disease Interventional Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Structural Heart Disease Interventional Device market opportunities vary by end market size?
How does Structural Heart Disease Interventional Device break out type, application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Structural Heart Disease Interventional Device Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Structural Heart Disease Interventional Device by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Structural Heart Disease Interventional Device by Country/Region, 2019, 2023 & 2030
2.2 Structural Heart Disease Interventional Device Segment by Type
2.2.1 Percutaneous Interventional Devices
2.2.2 Thoracotomy Instruments
2.3 Structural Heart Disease Interventional Device Sales by Type
2.3.1 Global Structural Heart Disease Interventional Device Sales Market Share by Type (2019-2024)
2.3.2 Global Structural Heart Disease Interventional Device Revenue and Market Share by Type (2019-2024)
2.3.3 Global Structural Heart Disease Interventional Device Sale Price by Type (2019-2024)
2.4 Structural Heart Disease Interventional Device Segment by Application
2.4.1 Congenital Heart Disease
2.4.2 Valvular Disease
2.4.3 Cardiomyopathy
2.4.4 Others
2.5 Structural Heart Disease Interventional Device Sales by Application
2.5.1 Global Structural Heart Disease Interventional Device Sale Market Share by Application (2019-2024)
2.5.2 Global Structural Heart Disease Interventional Device Revenue and Market Share by Application (2019-2024)
2.5.3 Global Structural Heart Disease Interventional Device Sale Price by Application (2019-2024)
3 Global Structural Heart Disease Interventional Device by Company
3.1 Global Structural Heart Disease Interventional Device Breakdown Data by Company
3.1.1 Global Structural Heart Disease Interventional Device Annual Sales by Company (2019-2024)
3.1.2 Global Structural Heart Disease Interventional Device Sales Market Share by Company (2019-2024)
3.2 Global Structural Heart Disease Interventional Device Annual Revenue by Company (2019-2024)
3.2.1 Global Structural Heart Disease Interventional Device Revenue by Company (2019-2024)
3.2.2 Global Structural Heart Disease Interventional Device Revenue Market Share by Company (2019-2024)
3.3 Global Structural Heart Disease Interventional Device Sale Price by Company
3.4 Key Manufacturers Structural Heart Disease Interventional Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Structural Heart Disease Interventional Device Product Location Distribution
3.4.2 Players Structural Heart Disease Interventional Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Structural Heart Disease Interventional Device by Geographic Region
4.1 World Historic Structural Heart Disease Interventional Device Market Size by Geographic Region (2019-2024)
4.1.1 Global Structural Heart Disease Interventional Device Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Structural Heart Disease Interventional Device Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Structural Heart Disease Interventional Device Market Size by Country/Region (2019-2024)
4.2.1 Global Structural Heart Disease Interventional Device Annual Sales by Country/Region (2019-2024)
4.2.2 Global Structural Heart Disease Interventional Device Annual Revenue by Country/Region (2019-2024)
4.3 Americas Structural Heart Disease Interventional Device Sales Growth
4.4 APAC Structural Heart Disease Interventional Device Sales Growth
4.5 Europe Structural Heart Disease Interventional Device Sales Growth
4.6 Middle East & Africa Structural Heart Disease Interventional Device Sales Growth
5 Americas
5.1 Americas Structural Heart Disease Interventional Device Sales by Country
5.1.1 Americas Structural Heart Disease Interventional Device Sales by Country (2019-2024)
5.1.2 Americas Structural Heart Disease Interventional Device Revenue by Country (2019-2024)
5.2 Americas Structural Heart Disease Interventional Device Sales by Type
5.3 Americas Structural Heart Disease Interventional Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Structural Heart Disease Interventional Device Sales by Region
6.1.1 APAC Structural Heart Disease Interventional Device Sales by Region (2019-2024)
6.1.2 APAC Structural Heart Disease Interventional Device Revenue by Region (2019-2024)
6.2 APAC Structural Heart Disease Interventional Device Sales by Type
6.3 APAC Structural Heart Disease Interventional Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Structural Heart Disease Interventional Device by Country
7.1.1 Europe Structural Heart Disease Interventional Device Sales by Country (2019-2024)
7.1.2 Europe Structural Heart Disease Interventional Device Revenue by Country (2019-2024)
7.2 Europe Structural Heart Disease Interventional Device Sales by Type
7.3 Europe Structural Heart Disease Interventional Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Structural Heart Disease Interventional Device by Country
8.1.1 Middle East & Africa Structural Heart Disease Interventional Device Sales by Country (2019-2024)
8.1.2 Middle East & Africa Structural Heart Disease Interventional Device Revenue by Country (2019-2024)
8.2 Middle East & Africa Structural Heart Disease Interventional Device Sales by Type
8.3 Middle East & Africa Structural Heart Disease Interventional Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Structural Heart Disease Interventional Device
10.3 Manufacturing Process Analysis of Structural Heart Disease Interventional Device
10.4 Industry Chain Structure of Structural Heart Disease Interventional Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Structural Heart Disease Interventional Device Distributors
11.3 Structural Heart Disease Interventional Device Customer
12 World Forecast Review for Structural Heart Disease Interventional Device by Geographic Region
12.1 Global Structural Heart Disease Interventional Device Market Size Forecast by Region
12.1.1 Global Structural Heart Disease Interventional Device Forecast by Region (2025-2030)
12.1.2 Global Structural Heart Disease Interventional Device Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Structural Heart Disease Interventional Device Forecast by Type
12.7 Global Structural Heart Disease Interventional Device Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.1.3 Abbott Laboratories Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.2.3 Boston Scientific Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Edwards Lifesciences
13.3.1 Edwards Lifesciences Company Information
13.3.2 Edwards Lifesciences Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.3.3 Edwards Lifesciences Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Edwards Lifesciences Main Business Overview
13.3.5 Edwards Lifesciences Latest Developments
13.4 Medtronic
13.4.1 Medtronic Company Information
13.4.2 Medtronic Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.4.3 Medtronic Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Medtronic Main Business Overview
13.4.5 Medtronic Latest Developments
13.5 Terumo
13.5.1 Terumo Company Information
13.5.2 Terumo Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.5.3 Terumo Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Terumo Main Business Overview
13.5.5 Terumo Latest Developments
13.6 B. Braun
13.6.1 B. Braun Company Information
13.6.2 B. Braun Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.6.3 B. Braun Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 B. Braun Main Business Overview
13.6.5 B. Braun Latest Developments
13.7 Lepu Medical
13.7.1 Lepu Medical Company Information
13.7.2 Lepu Medical Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.7.3 Lepu Medical Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lepu Medical Main Business Overview
13.7.5 Lepu Medical Latest Developments
13.8 Koninklijke Philips NV
13.8.1 Koninklijke Philips NV Company Information
13.8.2 Koninklijke Philips NV Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.8.3 Koninklijke Philips NV Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Koninklijke Philips NV Main Business Overview
13.8.5 Koninklijke Philips NV Latest Developments
13.9 Biosensors International
13.9.1 Biosensors International Company Information
13.9.2 Biosensors International Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.9.3 Biosensors International Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Biosensors International Main Business Overview
13.9.5 Biosensors International Latest Developments
13.10 Meril Life Sciences
13.10.1 Meril Life Sciences Company Information
13.10.2 Meril Life Sciences Structural Heart Disease Interventional Device Product Portfolios and Specifications
13.10.3 Meril Life Sciences Structural Heart Disease Interventional Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Meril Life Sciences Main Business Overview
13.10.5 Meril Life Sciences Latest Developments
14 Research Findings and Conclusion